Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Life Sciences
In Silico Screeing Of Natural Compounds As Novel Drug Targets For Treatment Of Multiple Myeloma, Rousselene Larson
In Silico Screeing Of Natural Compounds As Novel Drug Targets For Treatment Of Multiple Myeloma, Rousselene Larson
Student Research Symposium
In Silico Screening of Natural Compounds as Novel Drug Targets for The Treatment of Multiple MyelomaRousselene Larson1 2, Naveen Duhan1, and Rakesh Kaundal1 2 *1Department of Plants, Soils, and Climate, College of Agriculture and Applied Sciences; 2Bioinformatics Facility, Center for Integrated BioSystems; Utah State University, Logan, UT 84322 USA* corresponding author (e-mail: rkaundal@usu.edu)Telephone: +1 (435) 797-4117Fax: +1 (435) 797-2766Abstract: Multiple Myeloma (MM) is an incurable hematological malignancy cancer characterized by excessive clonal plasma cell proliferation in the bone marrow. In the United States, MM is the second most prevalent type of cancer that affects about 4 in 100,000 Americans. Toxicity …